Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway

Journal of Virology

Volumn 89, Issue 6, 2015, Pages 3356-3365

  Mukherjee, Anupam ^a   Di Bisceglie, Adrian M ^a   Ray, Ratna B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 9; JANUS KINASE; JANUS KINASE 1; MICRORNA; MICRORNA 373; STAT PROTEIN; STAT1 PROTEIN; UNCLASSIFIED DRUG; IRF9 PROTEIN, HUMAN; MIRN373 MICRORNA, HUMAN; STAT1 PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; GENE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTERFERON STIMULATED GENE; ISG FACTOR 3 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; PROTEIN TARGETING; SIGNAL TRANSDUCTION; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION; ADULT; ENZYMOLOGY; FEMALE; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; LIVER CELL; MALE; METABOLISM; PHYSIOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; JANUS KINASES; MALE; MICRORNAS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84923210986     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03085-14     Document Type: Article

References (32)

1. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr PJ. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 88:2451-2455. http://dx.doi.org/10.1073/pnas.88.6.2451.
2. Gravitz L. 2011. Introduction: a smouldering public-health crisis. Nature 474:S2-S4. http://dx.doi.org/10.1038/474S2a.
3. Thomas DL. 2013. Global control of hepatitis C: where challenge meets opportunity. Nat Med 19:850-858. http://dx.doi.org/10.1038/nm.3184.
4. Saha B, Szabo G. 2014. Innate immune cell networking in hepatitis C virus infection. J Leukoc Biol 96:757-766. http://dx.doi.org/10.1189/jlb .4MR0314-141R.
5. World Health Organization. 2014. Hepatitis C. World Health Organization, Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs 164/en/.
6. Meister G, Tuschl T. 2004. Mechanisms of gene silencing by double-stranded RNA. Nature 431:343-349. http://dx.doi.org/10.1038/nature02873.
7. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002.
8. Winter J, Jung S, Keller S, Gregory RI, Diederichs S. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228-234. http://dx.doi.org/10.1038/ncb0309-228.
9. Roberts AP, Lewis AP, Jopling CL. 2011. The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 102:101-139. http://dx.doi.org/10 .1016/B978-0-12-415795-8.00002-7.
10. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell .2006.02.015.
11. Shrivastava S, Mukherjee A, Ray RB. 2013. Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol 5:479-486. http://dx.doi.org/10.4254/wjh.v5.i9.479.
12. Cullen BR. 2013. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol 14:205-210. http://dx.doi.org/10.1038/ni.2537.
13. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. 2012. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol 86: 10221-10225. http://dx.doi.org/10.1128/JVI.00882-12.
14. Chen Y, Chen J, Wang H, Shi J, Wu K, Liu S, Liu Y, Wu J. 2013. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog 9:e1003248. http://dx.doi.org/10.1371/journal.ppat.1003248.
15. Li A, Song W, Qian J, Li Y, He J, Zhang Q, Li W, Zhai A, Kao W, Hu Y, Li H, Wu J, Ling H, Zhong Z, Zhang F. 2013. miR-122 modulates type I interferon expression through blocking suppressor of cytokine signaling 1. Int J Biochem Cell Biol 45:858-865. http://dx.doi.org/10.1016/j.biocel .2013.01.008.
16. Yoshikawa T, Takata A, Otsuka M, Kishikawa T, Kojima K, Yoshida H, Koike K. 2012. Silencing of microRNA-122 enhances interferon-α signaling in the liver through regulating SOCS3 promoter methylation. Sci Rep 2:637. http://dx.doi.org/10.1038/srep00637.
17. El-Ekiaby N, Hamdi N, Negm M, Ahmed R, Zekri AR, Esmat G, Abdelaziz AI. 2012. Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4. FEBS Open Bio 2:179-186. http://dx.doi.org/10.1016/j.fob.2012.07 .005.
18. Ray RB, Meyer K, Ray R. 2000. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271:197-204. http://dx.doi.org/10.1006/viro.2000.0295.
19. Kanda T, Basu A, Steele R, Wakita T, Ryerse JS, Ray R, Ray RB. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J Virol 80:4633-4639. http://dx.doi.org/10.1128/JVI.80.9.4633-4639.2006.
20. Shrivastava S, Bhanja Chowdhury J, Steele R, Ray R, Ray RB. 2012. Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. J Virol 86:8705-8712. http://dx.doi.org/10.1128/JVI.00616-12.
21. Mukherjee A, Shrivastava S, Bhanja Chowdhury J, Ray R, Ray RB. 2014. Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression. J Virol 88:7929-7940. http://dx.doi.org/10 .1128/JVI.00787-14.
22. Aaronson DS, Horvath CM. 2002. A road map for those who don't know JAK-STAT. Science 296:1653-1655. http://dx.doi.org/10.1126/science .1071545.
23. Mowen K, David M. 2000. Regulation of STAT1 nuclear export by Jak1. Mol Cell Biol 20:7273-7281. http://dx.doi.org/10.1128/MCB.20.19.7273-7281.2000.
24. Rani MRS, Ransohoff MR. 2005. Alternative and accessory pathways in the regulation of IFN-β-mediated gene expression. J Interferon Cytokine Res 25:788-798. http://dx.doi.org/10.1089/jir.2005.25.788.
25. Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. 2011. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol 85:12881-12889. http://dx.doi.org/10.1128/JVI.05633-11.
26. Devaux P, Priniski L, Cattaneo R. 2013. The measles virus phosphoprotein interacts with the linker domain of STAT1. Virology 444:250-256. http://dx.doi.org/10.1016/j.virol.2013.06.019.
27. Ren J, Kolli D, Liu T, Xu R, Garofalo RP, Casola A, Bao X. 2011. Human metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels. PLoS One 6:e24496. http://dx.doi.org/10 .1371/journal.pone.0024496.
28. Horner SM, Gale M, Jr. 2013. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 19:879-888. http://dx.doi.org/10.1038/nm .3253.
29. Shanker V, Trincucci G, Heim HM, Duong HT. 2013. Protein phosphatase 2A impairs IFNα-induced antiviral activity against the hepatitis C virus through the inhibition of STAT1 tyrosine phosphorylation. J Viral Hepat 20:612-621. http://dx.doi.org/10.1111/jvh.12083.
30. Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, Zhao H, Goto K, Peng LF, Chen WC, Chung RT. 2011. IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. J Hepatol 55:289-298. http://dx.doi.org/10.1016/j.jhep.2010.11.019.
31. Raychoudhuri A, Shrivastava S, Steele R, Dash S, Kanda T, Ray R, Ray RB. 2010. Hepatitis C virus infection impairs IRF-7 translocation and alpha interferon synthesis in immortalized human hepatocytes. J Virol 84:10991-10998. http://dx.doi.org/10.1128/JVI.00900-10.
32. Guo H, Liu H, Mitchelson K, Rao H, Luo M, Xie L, Sun Y, Zhang L, Lu Y, Liu R, Ren A, Liu S, Zhou S, Zhu J, Zhou Y, Huang A, Wei L, Guo Y, Cheng J. 2011. MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology 54: 808-819. http://dx.doi.org/10.1002/hep.24441.